Evolent Health, Inc (EVH): Price and Financial Metrics
GET POWR RATINGS... FREE!
EVH POWR Grades
- Growth is the dimension where EVH ranks best; there it ranks ahead of 87.97% of US stocks.
- The strongest trend for EVH is in Growth, which has been heading down over the past 177 days.
- EVH's current lowest rank is in the Quality metric (where it is better than 15.8% of US stocks).
EVH Stock Summary
- With a year-over-year growth in debt of 69.76%, EVOLENT HEALTH INC's debt growth rate surpasses 85.34% of about US stocks.
- In terms of twelve month growth in earnings before interest and taxes, EVOLENT HEALTH INC is reporting a growth rate of 301.68%; that's higher than 95.1% of US stocks.
- As for revenue growth, note that EVH's revenue has grown 48.91% over the past 12 months; that beats the revenue growth of 84.04% of US companies in our set.
- Stocks that are quantitatively similar to EVH, based on their financial statements, market capitalization, and price volatility, are MMYT, LIND, CJJD, INOD, and AGL.
- Visit EVH's SEC page to see the company's official filings. To visit the company's web site, go to www.evolenthealth.com.
EVH Valuation Summary
- In comparison to the median Technology stock, EVH's price/sales ratio is 4% higher, now standing at 2.6.
- EVH's price/sales ratio has moved NA NA over the prior 95 months.
Below are key valuation metrics over time for EVH.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
EVH | 2023-03-21 | 2.6 | 4.1 | -182.5 | -80.6 |
EVH | 2023-03-20 | 2.6 | 4.0 | -179.9 | -79.5 |
EVH | 2023-03-17 | 2.5 | 4.0 | -178.5 | -79.0 |
EVH | 2023-03-16 | 2.6 | 4.1 | -183.9 | -81.2 |
EVH | 2023-03-15 | 2.5 | 3.9 | -175.5 | -77.7 |
EVH | 2023-03-14 | 2.5 | 4.0 | -178.5 | -79.0 |
EVH Growth Metrics
- The 5 year cash and equivalents growth rate now stands at -34.85%.
- Its 5 year revenue growth rate is now at 188.1%.
- The 5 year price growth rate now stands at -63.43%.

The table below shows EVH's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 1,217.939 | 19.408 | -13.462 |
2022-06-30 | 1,087.825 | 67.379 | -28.625 |
2022-03-31 | 989.943 | 29.468 | -33.144 |
2021-12-31 | 907.957 | 38.747 | -37.601 |
2021-09-30 | 931.522 | -40.76 | -46.579 |
2021-06-30 | 973.644 | -105.76 | -70.887 |
EVH's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- EVH has a Quality Grade of D, ranking ahead of 14.15% of graded US stocks.
- EVH's asset turnover comes in at 0.713 -- ranking 221st of 563 Business Services stocks.
- EVOL, GLOB, and AKAM are the stocks whose asset turnover ratios are most correlated with EVH.
The table below shows EVH's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.713 | 0.254 | -0.052 |
2021-06-30 | 0.726 | 0.244 | -0.113 |
2021-03-31 | 0.742 | 0.245 | -0.547 |
2020-12-31 | 0.746 | 0.228 | -0.601 |
2020-09-30 | 0.704 | 0.220 | -0.869 |
2020-06-30 | 0.636 | 0.223 | -0.795 |
EVH Price Target
For more insight on analysts targets of EVH, see our EVH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $28.33 | Average Broker Recommendation | 1.43 (Moderate Buy) |
EVH Stock Price Chart Interactive Chart >
EVH Price/Volume Stats
Current price | $32.45 | 52-week high | $39.78 |
Prev. close | $31.99 | 52-week low | $21.83 |
Day low | $32.14 | Volume | 972,500 |
Day high | $32.68 | Avg. volume | 994,721 |
50-day MA | $32.30 | Dividend yield | N/A |
200-day MA | $31.75 | Market Cap | 3.60B |
Evolent Health, Inc (EVH) Company Bio
Evolent Health provides health-care delivery and payment solutions in the United States. The company was founded in 2011 and is based in Arlington, Virginia.
Latest EVH News From Around the Web
Below are the latest news stories about EVOLENT HEALTH INC that investors may wish to consider to help them evaluate EVH as an investment opportunity.
Evolent Health and Centene Agree to Expanded Partnership for Oncology Specialty Care for Medicare Advantage MembersEvolent Health, Inc. (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers, today announced an agreement to expand its Technology and Services solution for oncology with its existing partner, Centene Corporation, (NYSE: CNC). |
Investors in Evolent Health (NYSE:EVH) have made a massive return of 443% over the past three yearsEvolent Health, Inc. ( NYSE:EVH ) shareholders might be concerned after seeing the share price drop 12% in the last... |
Evolent Health to Participate in Upcoming ConferencesEvolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Financial Officer John Johnson and Vice President, Investor Relations, Seth Frank will participate in upcoming investor conferences, including meetings with institutional investors and presentations. |
Evolent Health Full Year 2022 Earnings: EPS Misses ExpectationsEvolent Health ( NYSE:EVH ) Full Year 2022 Results Key Financial Results Revenue: US$1.35b (up 49% from FY 2021). Net... |
Evolent Health Q4 Top-Line Beats Expectation, Analyst Points To Visible Growth OutlookEvolent Health Inc (NYSE: EVH) reported Q4 adjusted EPS of $0.10, missing the consensus of $0.16, compared to $0.08 a year ago. Revenues increased 54% Y/Y to $382.43 million, beating the consensus of $372.93 million. Total Lives on the Platform of 20.6 million as of Dec. 31, 2022, compared to 17.7 million a year ago. Total cases managed during the quarter within surgical management and advanced care planning totaled 15.7k, yielding an average per case revenue of $2.8k. Guidance: Evolent Health s |
EVH Price Returns
1-mo | -7.97% |
3-mo | 15.56% |
6-mo | -9.69% |
1-year | 0.46% |
3-year | 497.61% |
5-year | 127.72% |
YTD | 15.56% |
2022 | 1.48% |
2021 | 72.61% |
2020 | 77.13% |
2019 | -54.64% |
2018 | 62.20% |
Continue Researching EVH
Want to do more research on Evolent Health Inc's stock and its price? Try the links below:Evolent Health Inc (EVH) Stock Price | Nasdaq
Evolent Health Inc (EVH) Stock Quote, History and News - Yahoo Finance
Evolent Health Inc (EVH) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...